PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,991,991 | -30.8% | 660,690 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $12,996,000 | +22.9% | 660,690 | +100.6% | 0.00% | +50.0% |
| Q3 2021 | $10,572,000 | -5.2% | 329,343 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $11,148,000 | -9.9% | 329,343 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $12,370,000 | +13.1% | 329,343 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $10,941,000 | +15.0% | 329,343 | +27.0% | 0.00% | 0.0% |
| Q3 2020 | $9,510,000 | +11.4% | 259,343 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $8,535,000 | +27.5% | 259,343 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,696,000 | -32.2% | 259,343 | -18.3% | 0.00% | -33.3% |
| Q4 2019 | $9,881,000 | – | 317,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $40,675,000 | 10.18% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $114,625,000 | 8.82% |
| Abingworth LLP | 1,203,135 | $23,606,000 | 5.72% |
| RA Capital Management | 3,115,008 | $61,272,000 | 1.08% |
| Avidity Partners Management LP | 1,896,000 | $37,294,000 | 0.79% |
| StepStone Group LP | 422,085 | $8,302,000 | 0.47% |
| Summit Rock Advisors, LP | 34,100 | $671,000 | 0.40% |
| Parkman Healthcare Partners LLC | 77,481 | $1,524,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 186,210 | $3,624,000 | 0.24% |
| Ikarian Capital, LLC | 74,560 | $1,467,000 | 0.22% |